ConductScience.org, home

Paper1125

The effect of sulphydryl compounds and cross linking agents on the viscous and viscoelastic properties of mucus.

Davis SS and 2 others. Biorheology, 1975. Cited by 15 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The effect of sulphydryl compounds and cross linking agents on the viscous and viscoelastic properties of mucus. Papers, record 1125. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1125

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effect of sulphydryl compounds and cross linking agents on the viscous and viscoelastic properties of mucus.
PubMed
Journal
Biorheology
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
0.41
iCite
Revised in PubMed
2019-10-21
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Davis SSS S
2Scobie SS
3Inglis AA

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MucusMajor topic
Sulfhydryl CompoundsMajor topic
Animals
Calcium
Cervix Mucus
Elasticity
Gastric Mucosa
Hydrogen-Ion Concentration
Models, Biological
Rheology
Swine
Viscosity

Source PubMed

Download CSV of topics

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
28405161Mucoactive and antioxidant medicines for COPD: consensus of a group of Chinese pulmonary physicians.Int J Chron Obstruct Pulmon Dis2017https://conductscience.org/library/papers/28405161PubMed
26244017Positioning new pharmacotherapies for COPD.Int J Chron Obstruct Pulmon Dis2015https://conductscience.org/library/papers/26244017PubMed
25125976Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.Int J Chron Obstruct Pulmon Dis2014https://conductscience.org/library/papers/25125976PubMed
4031059Identification of gallbladder mucin-bilirubin complex in human cholesterol gallstone matrix. Effects of reducing agents on in vitro dissolution of matrix and intact gallstones.J Clin Invest1985https://conductscience.org/library/papers/4031059PubMed
115900Radioimmunoassay of human intestinal goblet cell mucin. Investigation of mucus from different organs and species.J Clin Invest1979https://conductscience.org/library/papers/115900PubMed
33658Enhancement of the viscosity of mucin by serum albumin.Biochem J1978https://conductscience.org/library/papers/33658PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1125

GET https://conductscience.org/api/papers/v1/1125/authors